Jimson weed intoxication in five adolescents

Wisconsin Medical Journal

Volumn 104, Issue 7, 2005, Pages 70-72

  Soneral, Steven N ^a,c   Connor, Neil P ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b St Mary's Hospital Medical Center   (United States)

^c Department of Family Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; LORAZEPAM; STRAMONIUM;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; COORDINATION DISORDER; DISORIENTATION; EMERGENCY WARD; HUMAN; HYPERACTIVITY; INGESTION; MALE; MUCOSAL DRYNESS; MYDRIASIS; PLANT INTOXICATION; SEDATION; SPEECH DISCRIMINATION; VISUAL HALLUCINATION;

ADOLESCENT; DATURA STRAMONIUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PLANT POISONING;

EID: 31444431993     PISSN: 10981861     EISSN: 10981861     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rosen CS, Lechner M. Jimson-weed intoxication. N Engl J Med. 1962;267:448-450.
2. Mikolich JR, Paulson GW, Cross CJ. Acute anticholinergic syndrome due to Jimson seed ingestion. clinical and laboratory observation in six cases. Ann Intern Med. 1975;83(3):321-325.
3. Ellenhorn M. Ellenhhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore: Williams and Wilkins;1997:306, 324, 840-845, 1865-1866.
4. Vanderhoff BT, Mosser KH. Jimson weed toxicity: management of anticholinergic plant ingestion. Am Fam Physician. 1992:46(2):526-530.
5. Goldfrank, L. Goldfrank's Toxicologic Emergencies. 7th ed. New York: McGraw-Hill; 2002:544-547, 1129-1158.
6. Coremans P, Lambrecht G, Schepens P, Vanwelden J, Verhaegen H. Anticholinergic intoxication with commercially available thorn apple tea. J Toxicol Clin Toxicol. 1994;32(5):589-592.
7. Delaney, K. Anticholinergics. In Rosen, P. Emergency Medicine Concepts and Clinical Practice. 3rd ed. St. Louis: Mosby Year Book;1992:2534-2540.
8. Rumack BH. Anticholinergic poisonings: treatment with physostigmine. Pediatrics. 1973;52:449-551.
9. Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med. 1980;9(11):588-590.
10. Suchard JR. Assessing physostigmine's contraindication in cyclic antidepressant ingestions. J Emerg Med. 2003;25(2):185-191.
11. Litovitz TL, Klein-Schwartz W, Dyer KS, Shannon M, Lee S, Powers M. 1997 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1998;16(5):482.
12. Litovitz TL, Klein-Schwartz W, Caravati EM, Youniss J, Crouch B, Lee S. 1998 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1999;17(5):474.
13. Litovitz TL, Klein-Schwartz W, White S, et al. 1999 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2000;18(5):559.
14. Litovitz TL, Klein-Schwartz W, White S, et al. 2000 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2001;19(5):381.
15. Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, et al. 2001 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2002;20(5):436.